Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
108.50    7.00 (6.90%)
Bid:
106.00
Ask:
111.00
Spread: 5.00 (4.717%)
Market Cap: £65.28m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Result of AGM

17 Sep 2014 16:25

RNS Number : 9600R
Intercede Group PLC
17 September 2014
 

Intercede Group plc

 

Result of Annual General Meeting ("AGM")

 

 

 

The AGM of Intercede Group plc was held on Wednesday 17 September 2014 at 2.00 pm.

 

All resolutions were passed on a poll. Resolutions 1 to 6 were passed as ordinary resolutions and resolutions 7 to 8 were passed as special resolutions. The number of ordinary shares in issue is 48,735,005.

 

 

For

% of votes cast

Against

% of votes cast

Withheld

Ordinary Resolutions

1. To receive and to adopt the Company's financial statements for the year ended 31 March 2014 together with the reports of the Directors and the auditors.

25,214,141

100.00

-

-

-

2. To re-elect Andrew Walker as a director.

25,214,091

100.00

50

-

-

3. To re-elect Ben Drury as a director.

25,206,147

99.98

4,396

0.02

3,958

4. To re-appoint PricewaterhouseCoopers LLP to hold office as auditors until the next Annual General Meeting, and to authorise the Directors to determine the remuneration of the auditors.

25,214,141

100.00

-

-

-

5. To approve the award of new share options under the existing Intercede Group plc Long Term Incentive Plan (LTIP).

21,320,925

84.64

3,868,216

15.36

25,000

6. To renew the authority given to the Directors to allot new securities.

25,195,091

99.92

19,050

0.08

-

Special Resolutions

7. To renew the authority given to the Directors to disapply pre-emption rights.

24,675,391

97.87

536,550

2.13

2,200

8. To renew the authority given to the Company to purchase its own shares.

25,214,091

100.00

50

-

 

 

The votes "for" figures include those votes at the discretion of the Chairman.

 

A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

 

Intercede Group plc will also publish this information on its website at www.intercede.com.

 

 

 

About Intercede

Intercede is a software company specializing in identity and credential management with a global team of experts located in the US and UK.

Intercede's MyID software enables organizations to create and use trusted digital identities for employees, citizens and machines. This allows secure access to services, facilities, information and networks.

MyID meets the highest government standards yet is simple enough to be deployed onto consumer devices such as smart phones and tablets. Critically, MyID provides an easy, convenient and secure alternative to passwords.

Millions of identities are managed using MyID and Intercede has provided identity verification and management services to global customers for more than 20 years. MyID is a commercial off the shelf software product, designed and developed to be configurable so it can be embedded as the cornerstone of cyber security infrastructure for governments and corporations.

Customers trusting Intercede for secure digital identity include the US and UK governments and some of the world's largest corporations, telecommunications providers and information technology partners.

For more information visit: www.intercede.com

 

Enquiries

 

Intercede Group plcTel.+44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director

 

finnCap LtdTel.+44 (0)207 220 0500Stuart Andrews, Corporate FinanceJoanna Weaving, Corporate Broking

 

Bell PottingerTel.+44 (0)7802 442486Archie Berens

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGQKODDPBKDACD
Date   Source Headline
23rd Jun 20267:00 amRNSFinal Results
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.